<ENAMEX TYPE="ORGANIZATION">Baxter International Inc.</ENAMEX>, citing cost-cutting moves and increased sales of its home-care products and dialysis treatments, posted a 20% rise in third-quarter net income on a 5.9% sales boost.
The <ENAMEX TYPE="LOCATION">Deerfield</ENAMEX>, <ENAMEX TYPE="LOCATION">Ill.</ENAMEX>, medical products and services company posted net of $102 million, or 34 cents a share, compared with $85 million, or 28 cents a share, a year ago. Sales totaled $1.81 billion up from $1.71 billion the previous year.
For the nine-month period, <ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX> said net rose 15% to $307 million, or $1.02 a share, from $267 million, or 89 cents a share, during the year-ago period.
Sales for the nine months were up 8% to $5.44 billion from $5.04 billion in the same period in 1988.
In <ENAMEX TYPE="ORGANIZATION">New York Stock Exchange</ENAMEX> composite trading, <ENAMEX TYPE="ORGANIZATION">Baxter</ENAMEX> closed at $22.25 a share, down 12.5 cents.
